TOCOSH FLOUR (Solanum tuberosum L.): A Toxicological Assessment of Traditional Peruvian Fermented Potatoes.
Jonas Roberto Velasco-ChongOscar Herrera-CalderonJuan Pedro Rojas-ArmasRenán Dilton Hañari-QuispeLinder Figueroa-SalvadorGilmar Peña-RojasVidalina Andía-AymeRicardo Ángel Yuli-PosadasAndres F Yepes-PerezCristian AguilarPublished in: Foods (Basel, Switzerland) (2020)
Potato tocosh is a naturally processed potato for nutritional and curative purposes from traditional Peruvian medicine. The aim of this study was to investigate the acute and sub-acute toxicity of tocosh flour (TF). For sub-acute toxicity, TF was administered orally to rats daily once a day for 28 days at doses of 1000 mg/kg body weight (BW). Animals were observed for general behaviors, mortality, body weight variations, and histological analysis. At the end of treatment, relative organ weights, histopathology, hematological and biochemical parameters were analyzed. For acute toxicity, TF was administered orally to mice at doses of 2000 and 5000 mg/kg BW at a single dose in both sexes. Body weight, mortality, and clinical signs were observed for 14 days after treatment. The results of acute toxicity showed that the median lethal dose (LD50) value of TF is higher than 2000 g/kg BW but less than 5000 mg/Kg BW in mice. Death and toxicological symptoms were not found during the treatment. For sub-acute toxicity, we found that no-observed-adverse-effect levels (NOAEL) of TF in rats up to 1000 g/kg BW. There were statistically significant differences in body weight, and relative organ weight in the stomach and brain. No differences in hematological and biochemical parameters were observed when compared with the control group. For sub-acute toxicity, histopathological studies revealed minor abnormalities in liver and kidney tissues at doses of 5000 mg/Kg. Based on these results, TF is a traditional Peruvian medicine with high safety at up to 1000 mg/kg BW for 28 days in rats.
Keyphrases
- body weight
- liver failure
- respiratory failure
- aortic dissection
- drug induced
- oxidative stress
- gene expression
- cardiovascular events
- risk factors
- physical activity
- metabolic syndrome
- cardiovascular disease
- body mass index
- coronary artery disease
- type diabetes
- oxide nanoparticles
- rectal cancer
- combination therapy
- extracorporeal membrane oxygenation
- weight loss
- acute respiratory distress syndrome